showed a trendP = 0.15
However, ide‐cel patients with high baseline sVCAM‐1 or sIL‐2R showed a trend towards worse PFS (P = 0.15; P = 0.17) (Figure S7G,J ).
However, ide‐cel patients with high baseline sVCAM‐1 or sIL‐2R showed a trend towards worse PFS (P = 0.15; P = 0.17) (Figure S7G,J ).